In the Phase 3 trial of once-weekly semaglutide for weight loss, lean body mass decreased, but the proportion of lean body mass relative to total body mass with semaglutide remained stable (earlier trials of 3.0 mg liraglutide did not report lean body mass proportions)
They do not, however, address the question of the physiological role of the endogenously released GLP-1 in these mesolimbic areas
hdl:11370/b73f97da-e52c-44a3-ae19-2d0cfc80ce89
risk factor-based screening for gestational diabetes mellitus: Detection rates, gestation at diagnosis and outcome
While there is little evidence that these ingredients can effectively control weight loss, the brand emphasized in a statement to Business Insider that the ingredients had been tested in humans
Benito E, Blazquez E, Bosch MA (1998) Glucagon-like peptide-1-(736)amide increases pulmonary surfactant secretion through a cyclic adenosine 3,5-monophosphate-dependent protein kinase mechanism in rat type II pneumocytes